Symbols / SCPH
SCPH Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-12 15:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash - Stock Titan ue, 07 Oct 2025 07
- scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance hu, 07 Aug 2025 07
- scPharmaceuticals (NASDAQ:SCPH) adds US$26m to market cap in the past 7 days, though investors from five years ago are still down 41% - simplywall.st Fri, 11 Jul 2025 07
- MannKind completes acquisition of scPharmaceuticals; SCPH to be delisted from Nasdaq - Investing.com ue, 07 Oct 2025 07
- Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire Mon, 25 Aug 2025 07
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders - GlobeNewswire ue, 26 Aug 2025 07
- MannKind Corporation Announces Acquisition of scPharmaceuticals to Enhance Cardiorenal Portfolio and Accelerate Revenue Growth - Quiver Quantitative Mon, 25 Aug 2025 07
- MannKind Corporation to Acquire scPharmaceuticals: More Details Inside - Stocktwits Mon, 25 Aug 2025 07
- scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha hu, 22 May 2025 07
- scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit - Yahoo Finance Wed, 09 Jul 2025 07
- Market Sentiment Around Loss-Making scPharmaceuticals Inc. (NASDAQ:SCPH) - simplywall.st Fri, 16 May 2025 07
- MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish - Stocktwits ue, 26 Aug 2025 03
- >$370M annualized run rate: MannKind completes scPharmaceuticals acquisition, adds FUROSCIX - Stock Titan ue, 07 Oct 2025 07
- Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable - simplywall.st ue, 27 May 2025 07
- 2 "Strong Buy"-Rated Biotech Stocks With 303% to 446% Upside Potential - Barchart.com ue, 17 Dec 2024 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for SCPH
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|